Belgium vs Greece: HIV/AIDS deaths averted by antiretroviral therapy
Belgium
636.61 deaths
in 2024
Greece
553.75 deaths
in 2024
Belgium rank
85th
Greece rank
88th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Belgium
- Greece
How they compare
Belgium currently reports 636.61 deaths against 553.75 deaths in Greece, a difference of 82.86 deaths.
That makes Belgium's figure about 1.1 times Greece's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Greece ahead.
Belgium ranks 85th and Greece ranks 88th of 157 countries.
Belgium has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Belgium | Greece | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 99.54 deaths | 64.77 deaths | 34.77 deaths | Belgium |
| 2000s | 355.19 deaths | 267.56 deaths | 87.63 deaths | Belgium |
| 2010s | 595.22 deaths | 455.55 deaths | 139.67 deaths | Belgium |
| 2020s | 650.64 deaths | 550.71 deaths | 99.93 deaths | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Belgium or Greece?
- Belgium, at 636.61 deaths against 553.75 deaths in Greece as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Belgium and Greece?
- 82.86 deaths, with Belgium ahead.
- How many years of comparable data are there for Belgium and Greece?
- 35 years are reported by both, from 1990 to 2024.
- How do Belgium and Greece rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Belgium ranks 85th and Greece ranks 88th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.